Skip to main content
SpringerLink
Log in

Association between DPP-4 inhibitors and bullous pemphigoid in US

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Jedlowski PM, et al. DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020 American Journal of Clinical Dermatology : 21 Jul 2021. Available from: URL: https://doi.org/10.1007/s40257-021-00625-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Association between DPP-4 inhibitors and bullous pemphigoid in US. Reactions Weekly 1866, 5 (2021). https://doi.org/10.1007/s40278-021-99701-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-99701-x

Search

Navigation